SEC Charges TherapeuticsMD (TXMD) $2.80 With Regulation FD Violations
Washington D.C., Aug. 20, 2019 —
The Securities and Exchange Commission today charged TherapeuticsMD Inc., a pharmaceutical company headquartered...
Short Squeeze Alert.
Internet Stock Review Adds Ebix (EBIX) $39 to Watch List. Short Squeeze Coming? Price Target $110.
Emerald Organic Products, Inc. (EMOR) Announces Exclusive Licensing Agreement With PetVivo Holdings Inc. (PETV).
New York, NY, Aug. 05, 2019 (GLOBE NEWSWIRE) -- Emerald Organic Products, Inc. (OTC:EMOR) ("Emerald" or the "Company") is pleased to announce...
Stand Down III: Guess Who This Beautiful Chart Belongs to?
Answer Below..
$14 to $593. That's $140,000 to $5,930,000. That's Real Money.
My Size (MYSZ) Signs License Agreement With Penti for Smart Body Measurement Application MySizeID.
(In a country of 80 million people, there are a lot of women shopping for undies, hosiery,...
Biotech Stock Review Adding PetVivo (PETV) $0.23 to the Watch List.
Are We Catching a Falling Knife?
Don't Think So!
LIVE QUOTE
$230 Million Blank Check! As in blank.
Hats Off to Cantor and Northland Securities for Raising $230 Million to Invest in Something. Not Sure What, Just Something. Something...
Duos Technologies (DOUT) $0.70. Artificial Intelligence Made Easy. Grossly Undervalued.
Internet Stock Review Adds Duos Technologies ($0.70) to Watch List. Graduates to OTCQX 6/20/19.
Duos Technologies Website. Presentation...
Biotech Stock Review Adds NanoVibronix (NAOV) $2.95, to Watch List.
NanoVibronix Announces Closing of $3.2 Million Private Placement to Existing Shareholders.
Adding to Watch List @ $2.95*...
Latest article
Nine Page Summary Report on GeoVax (GOVX)
This is a great long-term story. We’re telling you.
(March 2024) When we finished writing our earlier...
GeoVax (GOVX) Provides First Half 2024 Business Update.
Award of BARDA Project NextGen contract represents a significant milestone event;
Total value...
Reverse Split Mania! Solgenix (SNGX) Jumps 448% After 1:16.
Can You Imagine Selling Solgenix at $2.00 yesterday.
And to be honest, news wasn't all that big - such...
